Screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation

2018411 citationsJournal Articlegreen Open Access

Authors

Min Yi Tan · King's College London

Argyro Syngelaki · King's College Hospital

Liona C. Poon · King's College London

Daniel L. Rolnik · King's College Hospital

N. O’Gorman · King's College Hospital

Juan Luis Delgado⋈ · Hospital Universitario Virgen de la Arrixaca

Ranjit Akolekar

Abstract

Screening by maternal factors and biomarkers at 11-13 weeks' gestation can identify a high proportion of pregnancies that develop early and preterm PE. © 2018 Crown copyright. Ultrasound in Obstetrics & Gynecology © 2018 ISUOG.

Topics & Keywords

Pregnancy and preeclampsia studies Birth, Development, and Health Prenatal Screening and Diagnostics

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Ultrasound in Obstetrics and Gynecology

Volume 52, Issue 2, pp. 186-195

DOI: 10.1002/uog.19112

Field-Weighted Citation Impact: 23.28